NEU 2.22% $20.26 neuren pharmaceuticals limited

Exactly.Thankfully, I don't think many people are putting much...

  1. 1,136 Posts.
    lightbulb Created with Sketch. 125
    Exactly.

    Thankfully, I don't think many people are putting much faith into Jabra's charts/squiggly lines. I agree, the intention of these posts is to sow the seed of doubt in wavering hands, particularly following the Culper report.

    I'd also like to point out and remind everyone, despite claiming the gap will be filled, not even a (hopefully soon to be proven to all) misleading and false report (i.e. deterioration of fundamentals) resulted in an unfavourable result as predicted by Jabra's charts/squiggly lines. The continuous posting only further destroy Jabra's charting credibility (not that I think there was much left to begin with).

    There are way too many defining events due over the next 6 months, the results of these will determine what the share price does over the next little while - and at this stage there is no evidence to suggest 2024 will not be a great year for suffers and holders.


    Last edited by prodigy1: 22/02/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.26
Change
0.440(2.22%)
Mkt cap ! $2.557B
Open High Low Value Volume
$19.89 $20.30 $19.77 $3.421M 170.3K

Buyers (Bids)

No. Vol. Price($)
4 72 $20.26
 

Sellers (Offers)

Price($) Vol. No.
$20.27 54 3
View Market Depth
Last trade - 13.36pm 07/05/2024 (20 minute delay) ?
Last
$20.25
  Change
0.440 ( 2.53 %)
Open High Low Volume
$19.86 $20.31 $19.77 55415
Last updated 13.57pm 07/05/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.